BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32340161)

  • 1. The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.
    Rizeq B; Malki MI
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis.
    Mohammed MM; Shaker O; Ramzy MM; Gaber SS; Kamel HS; Abed El Baky MF
    Life Sci; 2021 Aug; 279():119691. PubMed ID: 34102193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
    Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
    J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
    Jørgensen AS; Rosenkilde MM; Hjortø GM
    Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
    Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
    Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.
    Cai W; Tao J; Zhang X; Tian X; Liu T; Feng X; Bai J; Yan C; Han Y
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1933-41. PubMed ID: 24990231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in targeting therapy of cancer metastasis by CCL21/CCR7 axis].
    Zhang L; Wang F; Yao X; Ma S; Zhang L; Qin Z
    Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2741-2754. PubMed ID: 33398969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
    Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
    Database (Oxford); 2015; 2015():. PubMed ID: 26504105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
    Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
    J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
    Nandagopal S; Wu D; Lin F
    PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.
    Scandella E; Men Y; Legler DF; Gillessen S; Prikler L; Ludewig B; Groettrup M
    Blood; 2004 Mar; 103(5):1595-601. PubMed ID: 14592837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
    Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
    J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.